ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Marseille Cancer Research Center (CRCM) at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Marseille Cancer Research Center (CRCM) takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions centre on drug levels, treatment response, and toxicity in blood and solid cancers. They examine whether venetoclax concentrations predict response and toxicity in acute myeloid leukemia.

OrganizationESMO 2026 Attendance
University & institute
Cancer research institute in Marseille, France.
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
De-escalating IO drugs (MOIO trial): Interim pharmacokinetic and immunomonitoring analysis
Friday Poster Display session 2
Lung & thoracic cancersMelanoma & skin cancersGenitourinary cancers
Poster
Fri Oct 23
15:15–16:00
Nivolumab trough levels as early predictors of clinical outcome in metastatic melanoma
Friday Poster Display session 3
Melanoma & skin cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Marseille Cancer Research Center (CRCM)

Tell us what you sell and we’ll find the people at Marseille Cancer Research Center (CRCM) most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction